New eye drop put to the test in major dry eye safety trial
NCT ID NCT04735393
Summary
This study tested the safety of a new eye drop called reproxalap for people with dry eye disease. Over 750 participants used the eye drop or a placebo (inactive) drop for up to a year. The main goal was to check for serious side effects related to vision, eye pressure, and the health of the cornea and retina.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Andover Eye Associates
Andover, Massachusetts, 01810, United States
Conditions
Explore the condition pages connected to this study.